(IRON)
0.00
0.00 (0.00%)
Get all premium features to the best stock analysis tool
0.00
0.00 (0.00%)
| Breakdown | |
|---|---|
| 7.97% | % of Shares Held by All Insider |
| 104.48% | % of Shares Held by Institutions |
| 113.53% | % of Float Held by Institutions |
| 279 | Number of Institutions Holding Shares |
| Holder | Shares | Date Reported | % Out | Value |
|---|---|---|---|---|
| FMR, LLC | 5.45M | 2025-12-31 | 14.28% | $327.50M |
| Blackrock Inc. | 2.27M | 2025-12-31 | 5.96% | $136.70M |
| RA Capital Management, L.P. | 1.98M | 2025-12-31 | 5.18% | $118.75M |
| Vanguard Group Inc | 1.77M | 2025-12-31 | 4.63% | $106.22M |
| Price (T.Rowe) Associates Inc | 1.70M | 2025-12-31 | 4.45% | $102.03M |
| JPMORGAN CHASE & CO | 1.58M | 2025-12-31 | 4.14% | $95.01M |
| Wellington Management Group, LLP | 1.52M | 2025-12-31 | 3.98% | $91.23M |
| Atlas Venture Life Science Advisors, LLC | 1.51M | 2025-12-31 | 3.97% | $90.97M |
| Frazier Life Sciences Management, L.P. | 1.26M | 2025-12-31 | 3.30% | $75.71M |
| State Street Corporation | 1.19M | 2025-12-31 | 3.11% | $71.39M |
| Holder | Shares | Date Reported | % Out | Value |
|---|---|---|---|---|
| Fidelity Rutland Square TRT II-Strategic Advisers Fidelity U.S. Total | 1.42M | 2026-01-31 | 3.73% | $85.43M |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 926,409 | 2025-12-31 | 2.43% | $55.67M |
| Fidelity Select Portfolios-Select Health Care Portfolio | 700,000 | 2026-01-31 | 1.83% | $42.06M |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 623,704 | 2026-01-31 | 1.63% | $37.48M |
| iShares Trust-iShares Russell 2000 ETF | 593,302 | 2026-01-31 | 1.55% | $35.65M |
| Fidelity Select Portfolios-Select Biotechnology Portfolio | 581,074 | 2026-01-31 | 1.52% | $34.92M |
| T. Rowe Price New Horizons Fund, Inc. | 471,851 | 2025-12-31 | 1.24% | $28.35M |
| Fidelity Securities Fund-Fidelity Small Cap Growth Fund | 398,364 | 2025-12-31 | 1.04% | $23.94M |
| MUTUAL FUND SERIES TRUST-Eventide Healthcare & Life Sciences Fund | 395,235 | 2025-12-31 | 1.04% | $23.75M |
| T. Rowe Price Health Sciences Fund, Inc. | 394,643 | 2025-12-31 | 1.03% | $23.71M |
| JPMorgan Trust II-JPMorgan Mid Cap Growth Fund | 389,264 | 2025-12-31 | 1.03% | $25.99M |